Will Virtual Reality Roller-Coasters Draw More Crowds Than Real Ones?
Six Flags Entertainment has announced a partnership with Samsung to launch virtual reality coasters at nine of its parks.
Six Flags Entertainment has announced a partnership with Samsung to launch virtual reality coasters at nine of its parks.
Darden Restaurants reported its better-than-expected fiscal third-quarter financial results before the markets opened on Tuesday.
Oppenheimer believes that the turmoil in capital markets will pressure trading, investment banking and asset management revenues.
The trade deficit came in at a wider-than-expected $47 billion in February, primarily due to a rising cross-border demand.
Walgreens Boots Alliance is scheduled to report its fiscal second-quarter financial results before the markets open on Tuesday.
Groupon announced it has entered into an agreement for a $250 million investment from private firm Atairos. The CEO of Atairos will join Groupon's board of directors
Darden Restaurants is set to report its fiscal third-quarter earnings Tuesday before the markets open.
Brocade Communications Systems aims to acquire Ruckus Wireless in a transaction valued at more than a billion dollars.
At the end of March, a district court granted the request from Depomed and lifted the stay of its patent infringement suit against Purdue.
Despite the rocky drop in oil prices over the past year, Chevron still remains a top pick in the integrated oil sector for Jefferies.
Not only does Aldeyra Therapeutics have a good cash position, but it also it has a strong pipeline as well. One key analyst has decided to weigh in on the firm and where it…
24/7 Wall St. has put together a preview Rite Aid, Walgreens and some of the major companies reporting their quarterly results this week.
Many analysts weighed in on Lululemon Athletica after its earnings report, speculating where it can go from here.
Dollar General, which has boosted its annual dividend, has received high praise from investors and analysts recently.
Over the past week, Opko Health, Acadia Pharmaceuticals and a few other biotech companies made impressive runs.
After much waiting, the broad markets and the Dow Jones Industrial Average in particular have made it back to positive territory.
Despite beating on the bottom line, the Micron Technology Inc. (NASDAQ: MU) results were not enough to sway investor sentiment.
Akari Therapeutics has announced preliminary results from the first paroxysmal nocturnal hemoglobinuria patient treated with subcutaneously administered Coversin.
TrueCar has posted its 27th consecutive month of year-over-year revenue expansion, but the share price plunged on Friday.
Regeneron Pharmaceuticals has announced that two Phase 3 studies evaluating investigational dupilumab in adult patients with inadequately controlled moderate-to-severe atopic dermatitis met their primary endpoints.